https://www.selleckchem.com/products/PLX-4032.html
Recent data suggest a decreased clinical efficacy of low-dose aspirin in patients weighing ≥70kg. We therefore investigated the impact of body weight and class 1 obesity on thromboxane generation and platelet reactivity to arachidonic acid (AA) in 316 patients on dual antiplatelet therapy following angioplasty and stenting. Platelet surface expression of P-selectin and activated glycoprotein (GP) IIb/IIIa in response to AA were determined by flow cytometry as sensitive markers of platelet activation. Urinary 11-dehydro-thromboxane B2 (
Like
Comment
Share
